Search Results - "Ffrench, R. A."

Refine Results
  1. 1

    Immunogenicity of a Human Immunodeficiency Virus (HIV) Polytope Vaccine Containing Multiple HLA A2 HIV CD8+ Cytotoxic T-Cell Epitopes by Woodberry, T, Gardner, J, Mateo, L, Eisen, D, Medveczky, J, Ramshaw, I A, Thomson, S A, Ffrench, R A, Elliott, S L, Firat, H, Lemonnier, F A, Suhrbier, A

    Published in Journal of Virology (01-07-1999)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  2. 2

    Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users by Flynn, J. K., Dore, G. J., Hellard, M., Yeung, B., Rawlinson, W. D., White, P. A., Kaldor, J. M., Lloyd, A. R., Ffrench, R. A.

    Published in Journal of viral hepatitis (01-08-2011)
    “…The critical events in clearance or persistence of hepatitis C virus (HCV) infection are unknown but likely to be determined early in acute infection. Type 1…”
    Get full text
    Journal Article
  3. 3

    Intrahepatic and peripheral blood virus-specific cytotoxic T lymphocyte activity is associated with a response to combination IFN-α and ribavirin treatment among patients with chronic hepatitis C virus infection by Freeman, A. J., Marinos, G., Ffrench, R. A., Lloyd, A. R.

    Published in Journal of viral hepatitis (01-03-2005)
    “…This report describes an association between intrahepatic and peripheral blood cytotoxic T lymphocytes (CTL) activity present prior to receiving treatment, and…”
    Get full text
    Journal Article
  4. 4

    Reduced memory B‐cell populations in boys with B‐cell dysfunction after bone marrow transplantation for X‐linked severe combined immunodeficiency by Ting, S. S., Tangye, S. G., Wood, J., Ffrench, R. A., Ziegler, J. B.

    Published in British journal of haematology (01-03-2001)
    “…X‐linked severe combined immunodeficiency (XSCID) is a lethal disease resulting in death in infancy. In many instances, haploidentical bone marrow…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individuals by Benson, E M, Clarkson, J, Law, M, Marshall, P, Kelleher, A D, Smith, D E, Patou, G, Stewart, G J, Cooper, D A, French, R A

    Published in AIDS research and human retroviruses (20-01-1999)
    “…This study evaluates the impact of therapeutic vaccination with p24-VLP and zidovudine on the induction or maintenance of HIV-specific cytotoxic lymphocyte…”
    Get more information
    Journal Article
  9. 9

    Human dendritic cells pulsed with specific lipopeptides stimulate autologous antigen-specific T cells without the addition of exogenous maturation factors by Jones, K. L., Brown, L. E., Eriksson, E. M. Y., Ffrench, R. A., Latour, P. A., Loveland, B. E., Wall, D. M., Roberts, S. K., Jackson, D. C., Gowans, E. J.

    Published in Journal of viral hepatitis (01-10-2008)
    “…Serum‐free culture conditions to generate immature human monocyte‐derived DC (Mo‐DC) were optimized, and the parameters that influence their maturation after…”
    Get full text
    Journal Article
  10. 10

    In vitro HIV-specific CTL activity from HIV-seropositive individuals is augmented by interleukin-12 (IL-12) by Young, J M, Ffrench, R A, Clarkson, J D, Stewart, G J, Liang, T, Tideman, R L, Packham, D, Fulcher, D A, Benson, E M

    Published in AIDS research and human retroviruses (10-02-2001)
    “…IL-12 production is reduced in HIV infection, and recombinant human IL-12 (rhIL-12) augments in vitro HIV-specific proliferative responses in PBMC from…”
    Get more information
    Journal Article
  11. 11

    Immunopathogenesis of hepatitis C virus infection by Freeman, Anthony J, Marinos, George, Ffrench, Rosemary A, Lloyd, Andrew R

    Published in Immunology and cell biology (01-12-2001)
    “…Hepatitis C virus, a recently identified member of the family Flaviviridae, is an important cause of chronic viral hepatitis and cirrhosis. There are…”
    Get full text
    Journal Article
  12. 12

    Class II-restricted T-cell clones to a synthetic peptide of influenza virus hemagglutinin differ in their fine specificities and in the ability to respond to virus by FFRENCH, R. A, XI-LIN TANG, ANDERS, E. M, JACKSON, D. C, WHITE, D. O, DRUMMER, H, WADE, J. D, TREGEAR, G. W, BROWN, L. E

    Published in Journal of Virology (01-07-1989)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Quantification of Hepatitis C Virus in Human Liver and Serum Samples by Using LightCycler Reverse Transcriptase PCR by WHITE, Peter A, YONG PAN, FREEMAN, Anthony J, MARINOS, George, FFRENCH, Rosemary A, LLOYD, Andrew R, RAWLINSON, William D

    Published in Journal of Clinical Microbiology (01-11-2002)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  15. 15

    Distinct epitopes recognized by I-Ad-restricted T-cell clones within antigenic site E on influenza virus hemagglutinin by BROWN, L. E, FFRENCH, R. A, GAWLER, J. M, JACKSON, D. C, DYALL-SMITH, M. L, ANDERS, E. M, TREGEAR, G. W, DUNCAN, L, UNDERWOOD, P. A, WHITE, D. O

    Published in Journal of Virology (01-01-1988)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  16. 16

    Increased frequency of CCR-5 Delta 32 heterozygotes among long-term non-progressors with HIV-1 infection by Stewart, G J, Ashton, L J, Biti, R A, Ffrench, R A, Bennetts, B H, Newcombe, N R, Benson, E M, Carr, A, Cooper, DA, Kaldor, J M

    Published in AIDS (London) (01-12-1997)
    “…Background: The beta -chemokine receptor CCR-5 is used as a coreceptor by macrophage-tropic strains of HIV-1 to gain entry into CD4+ cells. Objective: To…”
    Get full text
    Journal Article
  17. 17

    Transmembrane T‐cell receptor peptides inhibit B‐ and natural killer‐cell function by Huynh, Nghi T., Ffrench, Rosemary A., Boadle, Ross A., Manolios, Nicholas

    Published in Immunology (01-04-2003)
    “…Summary A synthetic hydrophobic peptide (core peptide; CP) containing two positively charged amino acids, lysine and arginine was derived from the…”
    Get full text
    Journal Article
  18. 18

    Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: Associations with viral replication and progression by Keoshkerian, Elizabeth, Ashton, Lesley J., Smith, Danielle G., Ziegler, John B., Kaldor, John M., Cooper, David A., Stewart, Graeme J., Ffrench, Rosemary A.

    Published in Journal of medical virology (01-12-2003)
    “…Ex vivo effector cytotoxic T‐lymphocyte (CTL) activity was assessed in 27 members of the Australian Long‐Term Nonprogressor cohort and correlated with genetic,…”
    Get full text
    Journal Article
  19. 19

    Characterization of subtype-specific and cross-reactive helper-T-cell clones recognizing influenza virus hemagglutinin by Brown, L E, Katz, J M, Ffrench, R A, Anders, E M, White, D O

    Published in Cellular immunology (01-10-1987)
    “…The specificity and function of two T-cell clones derived from A/Memphis/1/71 (H3) influenza virus (Mem 71)-immune BALB/c spleen cells have been compared. One…”
    Get more information
    Journal Article
  20. 20

    A preliminary study to determine the effect of an infusion of cryopreserved autologous lymphocytes on immunocompetence and viral load in HIV-infected patients by TRICKETT, A. E, KELLY, M, CAMERON, B. A, LLOYD, A, FFRENCH, R. A, DWYER, J. M

    “…Therapeutic measures aimed at boosting the immunity of HIV-infected patients are a critical component of strategies for effective therapy of HIV and AIDS. To…”
    Get full text
    Journal Article